Literature DB >> 22475277

Therapeutic potential of mitochondrial translation inhibition for treatment of acute myeloid leukemia.

Aaron D Schimmer, Marko Skrtić.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22475277     DOI: 10.1586/ehm.12.8

Source DB:  PubMed          Journal:  Expert Rev Hematol        ISSN: 1747-4094            Impact factor:   2.929


× No keyword cloud information.
  10 in total

1.  AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells.

Authors:  Shanshan Pei; Mohammad Minhajuddin; Biniam Adane; Nabilah Khan; Brett M Stevens; Stephen C Mack; Sisi Lai; Jeremy N Rich; Anagha Inguva; Kevin M Shannon; Hyunmin Kim; Aik-Choon Tan; Jason R Myers; John M Ashton; Tobias Neff; Daniel A Pollyea; Clayton A Smith; Craig T Jordan
Journal:  Cell Stem Cell       Date:  2018-06-14       Impact factor: 24.633

2.  Mitochondria "fuel" breast cancer metabolism: fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells.

Authors:  Federica Sotgia; Diana Whitaker-Menezes; Ubaldo E Martinez-Outschoorn; Ahmed F Salem; Aristotelis Tsirigos; Rebecca Lamb; Sharon Sneddon; James Hulit; Anthony Howell; Michael P Lisanti
Journal:  Cell Cycle       Date:  2012-11-21       Impact factor: 4.534

3.  Feature genes predicting the FLT3/ITD mutation in acute myeloid leukemia.

Authors:  Chenglong Li; Biao Zhu; Jiao Chen; Xiaobing Huang
Journal:  Mol Med Rep       Date:  2016-05-12       Impact factor: 2.952

4.  Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling.

Authors:  Rebecca Lamb; Gloria Bonuccelli; Béla Ozsvári; Maria Peiris-Pagès; Marco Fiorillo; Duncan L Smith; Generoso Bevilacqua; Chiara Maria Mazzanti; Liam A McDonnell; Antonio Giuseppe Naccarato; Maybo Chiu; Luke Wynne; Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Oncotarget       Date:  2015-10-13

5.  A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia.

Authors:  Gregory A Reed; Gary J Schiller; Suman Kambhampati; Martin S Tallman; Dan Douer; Mark D Minden; Karen W Yee; Vikas Gupta; Joseph Brandwein; Yulia Jitkova; Marcela Gronda; Rose Hurren; Aisha Shamas-Din; Andre C Schuh; Aaron D Schimmer
Journal:  Cancer Med       Date:  2016-10-13       Impact factor: 4.452

Review 6.  The Antibiotic Drug Tigecycline: A Focus on its Promising Anticancer Properties.

Authors:  Zhijie Xu; Yuanliang Yan; Zhi Li; Long Qian; Zhicheng Gong
Journal:  Front Pharmacol       Date:  2016-12-02       Impact factor: 5.810

Review 7.  Mitochondrial metabolism as a target for acute myeloid leukemia treatment.

Authors:  Svetlana B Panina; Jingqi Pei; Natalia V Kirienko
Journal:  Cancer Metab       Date:  2021-04-21

Review 8.  Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors.

Authors:  Xiaonan Zhang; Angelo de Milito; Maria Hägg Olofsson; Joachim Gullbo; Padraig D'Arcy; Stig Linder
Journal:  Int J Mol Sci       Date:  2015-11-13       Impact factor: 5.923

9.  A novel formulation of tigecycline has enhanced stability and sustained antibacterial and antileukemic activity.

Authors:  Yulia Jitkova; Marcela Gronda; Rose Hurren; Xiaoming Wang; Carolyn A Goard; Bozhena Jhas; Aaron D Schimmer
Journal:  PLoS One       Date:  2014-05-28       Impact factor: 3.240

10.  Assessment of Platelet Mitochondrial Respiration in a Pediatric Population: A Pilot Study in Healthy Children and Children with Acute Lymphoblastic Leukemia.

Authors:  Theia Lelcu; Anca M Bînă; Maria D Dănilă; Călin M Popoiu; Oana M Aburel; Smaranda T Arghirescu; Claudia Borza; Danina M Muntean
Journal:  Children (Basel)       Date:  2021-12-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.